Abstract
In this study, a series of resveratrol analogs was synthesized and the effects on the viability of pancreatic cancer cell lines were evaluated. The new molecules were designed by removing the 3- and 5-OH groups of resveratrol, and by incorporating other substituents in 4-position, or by replacing the dihydroxybenzene with other aromatic systems. In all compounds the 4′-OH was kept unalterated. The effects of the compounds on cell viability were analyzed in three pancreatic cancer cell lines with distinct genetic profiles. Several compounds (e.g., 5, 9, and 12) exhibited improved cytotoxic activities as compared to the reference compounds, making them potential candidates for further evaluation as anticancer drugs.
Similar content being viewed by others
Abbreviations
- RSV:
-
resveratrol
- PC:
-
pancreatic cancer
- SLB:
-
stilbene
- 4-HSLB:
-
4′-hydroxystilbene
- TBSCl:
-
t-butyldimethylsilyl chloride
- NEt3 :
-
triethylamine
- TBAF:
-
tetra-n-butylammonium fluoride
References
Ammazzalorso A, De Lellis L, Florio R, Bruno I, De Filippis B, Fantacuzzi M, Giampietro L, Maccallini C, Perconti S, Verginelli F, Cama A, Amoroso R (2017) Cytotoxic effect of a family of peroxisome proliferator-activated receptor antagonists in colorectal and pancreatic cancer cell lines. Chem Biol Drug Des. 90:1029–1035
Ansari D, Tingstedt B, Andersson B, Holmquist F, Sturesson C, Williamsson C, Sasor A, Borg D, Bauden M, Andersson R (2016) Pancreatic cancer: yesterday, today and tomorrow. Future Oncol 12:1929–1946
Block G, Patterson B, Subar A (1992) Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 18:1–29
Bonnefont-Rousselot D (2016) Resveratrol and cardiovascular diseases. Nutrients 8:250–274
Britton RG, Kovoor C, Brown K (2015) Direct molecular targets of resveratrol: identifying key interactions to unlock complex mechanisms. Ann N Y Acad Sci 1348:124–133
Carter LG, D’Orazio JA, Pearson KJ (2014) Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer 21:R209–R225
Chillemi R, Sciuto S, Spatafora C, Tringali C (2007) Anti-tumor properties of stilbene-based resveratrol analogues: recent results. Nat Prod Commun 2:1–15
Chou Y-C, Ho C-T, Pan M-H (2018) Stilbenes: chemistry and molecular mechanisms of anti-obesity. Curr Pharmacol Rep 4:202–209
Deck LM, Whalen LJ, Hunsaker LA, Royer RE, Vander Jagt DL (2017) Activation of anti-oxidant Nrf2 signaling by substituted trans stilbenes. Bioorg Med Chem 25:1423–1430
De Filippis B, Agamennone M, Ammazzalorso A, Bruno I, D’Angelo A, Di Matteo M, Fantacuzzi M, Giampietro L, Giancristofaro A, Maccallini C, Amoroso R (2015a) PPARα agonists based on the stilbene and its bioisosters: biological evaluation and docking studies. Med Chem Commun 6:1513–1517
De Filippis B, Ammazzalorso A, Amoroso R, Giampietro L (2019) Stilbene derivatives as new perspective in antifungal medicinal chemistry. Drug Dev Res. https://doi.org/10.1002/ddr.21525
De Filippis B, Ammazzalorso A, Fantacuzzi M, Giampietro L, Maccallini C, Amoroso R (2017) Anticancer activity of stilbene based derivatives. ChemMedChem 12:558–570
De Filippis B, Giancristofaro A, Ammazzalorso A, D’Angelo A, Fantacuzzi M, Giampietro L, Maccallini C, Petruzzelli M, Amoroso R (2011) Discovery of gemfibrozil analogues that activate PPARα and enhance the expression of gene CPT1A involved in fatty acids catabolism. Eur J Med Chem 46:5218–5224
De Filippis B, Linciano P, Ammazzalorso A, Di Giovanni C, Fantacuzzi M, Giampietro L, Laghezza A, Maccallini C, Tortorella P, Lavecchia A, Loiodice F, Amoroso R (2015b) Structural development studies of PPARs ligands based on tyrosine scaffold. Eur J Med Chem 89:817–825
De la Castra CA, Villegas I (2007) Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans 35:1156–1160
de Sá Coutinho D, Pacheco MT, Frozza RL, Bernardi A (2018) Anti-inflammatory effects of resveratrol: mechanistic insights. Int J Mol Sci 19:1812–1837
Diaz-Gerevini GT, Repossi G, Dain A, Tarres MC, Das UN, Eynard AR (2016) Beneficial action of resveratrol: How and why? Nutrition 32:174–178
Ding XZ, Adrian TE (2002) Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Pancreas 25:71–76
dos Santos JC, Bernardes A, Giampietro L, Ammazzalorso A, De Filippis B, Amoroso R, Polikarpov I (2015) Different binding and recognition modes of GL479, a dual agonist of peroxisome proliferator-activated receptor α/γ. J Struct Biol 191:332–340
Duan J, Yue W, E J, Malhotra J, Lu SE, Gu J, Xu F, Tan XL (2016) In vitro comparative studies of resveratrol and triacetylresveratrol on cell proliferation, apoptosis, and STAT3 and NFκB signaling in pancreatic cancer cells. Sci Rep 19:31672–31682
Elshaer M, Chen Y, Wang XJ, Tang X (2018) Resveratrol: an overview of its anti-cancer mechanisms. Life Sci 207:340–349
Florio R, De Lellis L, di Giacomo V, Di Marcantonio MC, Cristiano L, Basile M, Verginelli F, Verzilli D, Ammazzalorso A, Prasad SC, Cataldi A, Sanna M, Cimini A, Mariani-Costantini R, Mincione G, Cama A (2017) Effects of PPARα inhibition in head and neck paraganglioma cells. PLoS ONE 12:e0178995
Florio R, De Lellis L, Veschi S, Verginelli F, di Giacomo V, Gallorini M, Perconti S, Sanna M, Mariani-Costantini R, Natale A, Arduini A, Amoroso R, Cataldi A, Cama A (2018) Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells. Sci Rep 11(8):13610
Garcia GX, Larsen SW, Pye C, Galbreath M, Isovitsch R, Fradinger EA (2013) The functional group on (E)-4,4′-disubstituted stilbenes influences toxicity and antioxidative activity in differentiated PC-12 cells. Bioorg Med Chem Lett 23:6355–6359
Giacomini E, Rupiani S, Guidotti L, Recanatini M, Roberti M (2016) The use of stilbene scaffold in medicinal chemistry and multi-target drug design. Curr Med Chem 23:2439–2489
Giampietro L, D’Angelo A, Giancristofaro A, Ammazzalorso A, De Filippis B, Di Matteo M, Fantacuzzi M, Linciano P, Maccallini C, Amoroso R (2014) Effect of stilbene and chalcone scaffolds incorporation in clofibric acid on PPARα agonistic activity. Med Chem 10:59–65
Giampietro L, D’Angelo A, Giancristofaro A, Ammazzalorso A, De Filippis B, Fantacuzzi M, Linciano P, Maccallini C, Amoroso R (2012) Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs. Bioorg Med Chem Lett 22:7662–7666
Giampietro L, Laghezza A, Cerchia C, Florio R, Recinella L, Capone F, Ammazzalorso A, Bruno I, De Filippis B, Fantacuzzi M, Ferrante C, Maccallini C, Tortorella P, Verginelli F, Brunetti L, Cama A, Amoroso R, Loiodice F, Lavecchia A (2019) Novel phenyldiazenyl fibrate analogues as PPAR α/γ/δ pan-agonists for the amelioration of metabolic syndrome. ACS Med Chem Lett 10:545–551
Herrera-R A, Castrillón W, Otero E, Ruiz E, Carda M, Agut R, Naranjo T, Moreno G, Maldonado ME (2018) Synthesis and antiproliferative activity of 3- and 7-styrylcoumarins. Med Chem Res 27:1893–1905
Huang X, Zhu HL (2011) Resveratrol and its analogues: promising antitumor agents. Anticancer Agents Med Chem 11:479–490
Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218–222
Kim JY, Lee JW, Kim YS, Lee Y, Ryu YB, Kim S, Ryu HW, Curtis-Long MJ, Lee KW, Lee WS, Park KH (2010) A novel competitive class of α-glucosidase inhibitors: (E)-1-phenyl-3-(4-styrylphenyl)urea derivatives. ChemBioChem 11:2125–2131
Kondratyuk TP, Park EJ, Marler LE, Ahn S, Yuan Y, Choi Y, Yu R, van Breemen R, Sun B, Hoshino J, Cushman M, Jermihov KC, Mesecar AD, Grubbs CJ, Pezzuto JM (2011) Resveratrol derivatives as promising chemopreventive agents with improved potency and selectivity. Mol Nutr Food Res 5:1249–1265
Kruk J, Aboul-Enein HY (2017) Reactive oxygen and nitrogen species in carcinogenesis: implications of oxidative stress on the progression and development of several cancer types. Mini Rev Med Chem 17:904–919
Lazer ES, Wong H-C, Wegner CD, Graham AG, Farinas PR (1990) Effect of structure on potency and selectivity in 2,6-disubstituted 4-(2-arylethenyl)phenol lipoxygenase inhibitors. J Med Chem 33:1892–1898
Leporini L, Giampietro L, Amoroso R, Ammazzalorso A, Fantacuzzi M, Menghini L, Maccallini C, Ferrante C, Brunetti L, Orlando G, De Filippis B (2017) In vitro protective effects of resveratrol and stilbene alkanoic derivatives on induced oxidative stress on C2C12 and MCF7 cells. J Biol Regul Homeost Agents 31:589–601
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Method 16:55–63
Murty MSR, Penthala R, Polepalli S, Jain N (2016) Synthesis and biological evaluation of novel resveratrol-oxadiazole hybrid heterocycles as potential antiproliferative agents. Med Chem Res 25:627–643
Ono K, Yoshiike Y, Takashima A, Hasegawa K, Naiki H, Yamada M (2003) Potent antiamyloidogenic and fibril-destabilizing effects of polyphenols in vitro: Implications for the prevention and therapeutics of Alzheimer’s disease. J Neurochem 87:172–181
Orgován G, Gonda I, Noszál B (2017) Biorelevant physicochemical profiling of (E)- and (Z)-resveratrol determined from isomeric mixtures. J Pharm Biomed Anal 138:322–329
Queiroz AN, Gomes BA, Jr Moraes WM, Borges RS (2009) A theoretical antioxidant pharmacophore for resveratrol. Eur J Med Chem 44:1644–1649
Sadeghi A, Ebrahimi SSS, Golestani A, Meshkani R (2017) Resveratrol ameliorates palmitate‐induced inflammation in skeletal muscle cells by attenuating oxidative stress and JNK/NF‐κB pathway in a SIRT1‐independent mechanism. J Cell Biochem 118:2654–2663
Scherzberg MC, Kiehl A, Zivkovic A, Stark H, Stein J, Fürst R, Steinhilber D, Ulrich-Rückert S (2015) Structural modification of resveratrol leads to increased anti-tumor activity, but causes profound changes in the mode of action. Toxicol Appl Pharmacol 287:67–76
Shang Y-J, Qian Y-P, Liu X-D, Dai F, Shang X-L, Jia W-Q, Liu Q, Fang J-G, Zhou B (2009) Radical-scavenging activity and mechanism of resveratrol-oriented analogues: influence of the solvent, radical, and substitution. J Org Chem 74:5025–5031
Shim JS, Liu JO (2014) Recent advances in drug repositioning for the discovery of new anticancer drugs. Int J Biol Sci 10:654–663
Stivala LA, Savio M, Carafoli F, Perucca P, Bianchi L, Maga G, Forti L, Pagnoni UM, Albinii A, Prosperi E, Vannini V (2001) Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J Biol Chem 276:22586–22594
Teague A, Lim KH, Wang-Gillam A (2015) Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies. Ther Adv Med Oncol 7:68–84
Telek G, Regöly-Mérei J, Kovács GC, Simon L, Nagy Z, Hamar J, Jakab F (2001) The first histological demonstration of pancreatic oxidative stress in human acute pancreatitis. Hepatogastroenterology 48:1252–1258
Tsang SW, Guan YF, Wang J, Bian ZX, Zhang HJ (2016) Inhibition of pancreatic oxidative damage by stilbene derivative dihydro-resveratrol: implication for treatment of acute pancreatitis. Sci Rep 14:22859–22874
Veschi S, De Lellis L, Florio R, Lanuti P, Massucci A, Tinari N, De Tursi M, di Sebastiano P, Marchisio M, Natoli C, Cama A (2018) Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells. J Exp Clin Cancer Res 21:236
Xu Q, Zong L, Chen X, Jiang Z, Nan L, Li J, Duan W, Lei J, Zhang L, Ma J, Li X, Wang Z, Wu Z, Ma Q, Ma Z (2015) Resveratrol in the treatment of pancreatic cancer. Ann N Y Acad Sci 1348:10–19
Zhang W, Oya S, Kung M-P, Hou C, Maier DL, Kung HF (2005) Stilbenes as PET imaging agents for detecting β-amyloid plaques in the brain. J Med Chem 8:5980–5988
Acknowledgements
This study was supported by University “G. d’Annunzio” of Chieti local grants. The authors gratefully acknowledge Prof. Massimiliano Baldassarre of Institute of Medical Sciences, University of Aberdeen, for helpful comments and suggestions.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
De Filippis, B., De Lellis, L., Florio, R. et al. Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs. Med Chem Res 28, 984–991 (2019). https://doi.org/10.1007/s00044-019-02351-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-019-02351-3